| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.23▼ | 1.26▼ | 1.26▼ | 1.32▼ | 1.52▼ |
| MA10 | 1.31▼ | 1.33▼ | 1.33▼ | 1.34▼ | 1.66▼ |
| MA20 | 1.34▼ | 1.33▼ | 1.33▼ | 1.50▼ | 2.75▼ |
| MA50 | 1.31▼ | 1.42▼ | 1.46▼ | 1.74▼ | 6.08▼ |
| MA100 | 1.48▼ | 1.59▼ | 1.63▼ | 2.87▼ | 248.14▼ |
| MA200 | 1.66▼ | 1.72▼ | 1.78▼ | 4.17▼ | 319.26▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.021▼ | -0.011▼ | -0.008▼ | -0.001▼ | 1.080▲ |
| RSI | 37.276▼ | 37.652▼ | 37.281▼ | 24.346▼ | 30.638▼ |
| STOCH | 13.611▼ | 21.389 | 23.131 | 24.548 | 14.238▼ |
| WILL %R | -76.667▼ | -76.667▼ | -76.667▼ | -74.627 | -94.551▼ |
| CCI | -110.330▼ | -144.920▼ | -144.618▼ | -90.983 | -99.930 |
|
Thursday, November 05, 2026 05:30 AM
(NASDAQ:APVO), a clinical-stage biotechnology company developing novel multispecific immuno-oncology therapeutics, today announced an important clinical development milestone for mipletamig: a ...
|
|
Monday, August 24, 2026 06:02 AM
Aptevo Therapeutics, Inc. (NASDAQ: APVO) is currently focused on the continued clinical progress with mipletamig, a $1.5 million non-dilutive grant to advance APVO451, and the company’s recently ...
|
|
Tuesday, January 13, 2026 04:00 PM
The average one-year price target for Aptevo Therapeutics (NasdaqCM:APVO) has been revised to $7,711.20 / share. This is an increase of 1,700.00% from the prior estimate of $428.40 dated December 18, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 06/11/26 | 1.30 | 1.3228 | 1.2001 | 1.24 | 32,744 |
| 05/11/26 | 1.37 | 1.37 | 1.07 | 1.27 | 144,043 |
| 04/11/26 | 1.345 | 1.38 | 1.31 | 1.37 | 14,800 |
| 03/11/26 | 1.44 | 1.44 | 1.31 | 1.36 | 13,981 |
| 02/11/26 | 1.3925 | 1.3976 | 1.3294 | 1.35 | 22,983 |
| 30/10/26 | 1.36 | 1.3864 | 1.31 | 1.34 | 16,897 |
| 29/10/26 | 1.32 | 1.41 | 1.31 | 1.36 | 58,513 |
| 28/10/26 | 1.36 | 1.3699 | 1.26 | 1.30 | 42,173 |
| 27/10/26 | 1.55 | 1.58 | 1.2525 | 1.28 | 80,065 |
| 26/10/26 | 1.74 | 1.74 | 1.43 | 1.50 | 123,728 |
|
|
||||
|
|
||||
|
|